Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.21 | -26.57 |
PEG Ratio (TTM) | 0.00 | -7.62 |
P/S Ratio (TTM) | 4.09 | 46.05 |
P/B Ratio (TTM) | 0.18 | 31.80 |
P/FCF Ratio (TTM) | -0.27 | -10.19 |
Price to 5YR AVG Earnings Ratio | N/A | -7.71 |
Price to 5YR AVG FCF Ratio | N/A | -15.41 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -84.64% | -17.65% |
ROE (TTM) | -81.66% | 23.80% |
Net Profit Margin (TTM) | -1,615.79% | -505.58% |
ROIC 5YR AVG | N/A | -7.74% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5.73% | -1,181.97% | N/A |
Revenue | -25.00% | 1,010.13% | N/A |
Net Income | 1.51% | -1,909.13% | N/A |
Cash Flow | -6.49% | -2,818.34% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 14.81 | 5.84 |
Quick Ratio (TTM) | 14.81 | 5.62 |
D/E Ratio (TTM) | N/A | 1.14 |
Interest Coverage (TTM) | N/A | -8.39 |
Piotroski F-Score | 3 | 4 |
Altman Z-Score | N/A | 13.46 |
LTL to 5YR AVG FCF | N/A | 0.03 |
Shares Outstanding Growth 5YR AVG | N/A | 40.81% |